REED JOHN C 4/A
4/A · JOHNSON & JOHNSON · Filed Oct 31, 2024
Insider Transaction Report
Form 4/AAmended
REED JOHN C
EVP, Innovative Medicine, R&D
Transactions
- Tax Payment
Common Stock
2024-05-01$144.59/sh−10,984$1,588,177→ 14,577 total - Exercise/Conversion
Restricted Share Units
2024-05-01−25,255→ 50,510 total→ Common Stock (25,255 underlying) - Exercise/Conversion
Common Stock
2024-05-01+25,255→ 25,561 total
Footnotes (2)
- [F1]The Restricted Share Units awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.
- [F2]Shares withheld for payment of taxes upon vesting of Restricted Share Units.